Rare disease medicine

Search documents
Ultragenyx Pharmaceutical(RARE) - 2025 Q1 - Earnings Call Transcript
2025-05-06 21:00
Ultragenyx Pharmaceutical (RARE) Q1 2025 Earnings Call May 06, 2025 05:00 PM ET Speaker0 Good afternoon, and welcome to the Ultragenyx First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. At the end of the prepared remarks, you will have an opportunity to ask questions during the Q and A portion of the call. It is now my pleasure to turn the call over to Joshua Higa, Vice President of Investor Relations. Speaker1 Thank you. We have iss ...
Ultragenyx Pharmaceutical(RARE) - 2025 Q1 - Earnings Call Transcript
2025-05-06 21:00
Ultragenyx Pharmaceutical (RARE) Q1 2025 Earnings Call May 06, 2025 05:00 PM ET Company Participants Joshua Higa - VP - Investor RelationsEmil Kakkis - Founder, President, CEO & DirectorErik Harris - Executive VP & Chief Commercial OfficerHoward Horn - Executive VP of Corporate Strategy & CFOEric Crombez - Chief Medical Officer & Executive VPTazeen Ahmad - MD - US Equity ResearchGena Wang - MD - Biotech Equity ResearchYigal Nochomovitz - DirectorWill Soghikian - Vice President - Equity ResearchLiisa Bayko - ...
Mirum(MIRM) - 2024 Q4 - Earnings Call Transcript
2025-02-26 22:32
Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call February 26, 2025 04:30 PM ET Company Participants Andrew McKibben - Vice President of Investor Relations and FinanceChris Peetz - President and Chief Executive OfficerJoanne Quan - Chief Medical OfficerEric Bjerkholt - Chief Financial OfficerGavin Clark-Gartner - Director - Biotechnology Equity ResearchRyan Mcelroy - Equity Research AssociateRyan Deschner - Vice President - Equity ResearchJon Wolleben - Managing Director Conference Call Participants Je ...